Table 1. Study Measures Selected for Electronic Standing Orders
Screening*Adult ImmunizationsPatients With Diabetes
1. Cholesterol (≥20 years old in past 5 years)1. Tetanus-diphtheria§ (≥12 years old in past 10 years)1. Annual urine microalbumin
2. HDL cholesterol (≥20 years old in past 5 years)2. Pneumovax (≥65 years old ever recorded)2. Hemoglobin A1c in past 6 months
3. Mammogram (women ≥40 years old in past 2 years)3. Pneumovax (18–64 years/ high risk ever recorded)3. Annual HDL
4. Bone mineral density (women ≥65 years old)4. Influenza (≥50 years old in past year)4. Annual LDL
5. Influenza (18 to 49 years/high risk in past year)5. Annual triglycerides
6. Zoster (≥60 years old)
  • * U.S. Preventive Service Task Force recommendation level of evidence A or B (recommended or strongly recommended, benefits outweigh harms).

  • Centers for Disease Control and Prevention Advisory Committee on Immunization Practices guideline.

  • Expert consensus or clinical experience. Also included in the AHRQ National Healthcare Quality Report and American Diabetes Association 2008 guidelines.

  • § Tetanus-diphtheria vaccine includes those with an acellular pertussis component.

  • Patients with diabetes, heart disease, congestive heart failure, chronic obstructive pulmonary disease, chronic renal disease, or alcohol abuse.

  • Patients with diabetes, heart disease, congestive heart failure, asthma, chronic obstructive pulmonary disease, chronic renal disease, or alcohol abuse.

  • HDL, high-density lipoprotein; LDL, low-density lipoprotein.